期刊文献+

针对HER2/neu的siRNA对非小细胞肺癌细胞生长的抑制作用 被引量:3

Inhibition of tumor growth of non-small cell lung cancer by small interfering RNA targeting to HER2/neu gene
下载PDF
导出
摘要 目的:构建针对HER2/neu的RNA干涉载体,观察对HER2/neu表达抑制及抑制后对非小细胞肺癌生长的影响.方法:设计和合成长度为64nt的脱氧寡核苷酸链,退火互补成双链,克隆至pSUPER质粒载体,转化DH5α菌株,提取质粒,转染过表达HER2/neu的肺腺癌细胞系SPCA1,RTPCR检测HER2/neu的mRNA表达,Westernblot和间接免疫荧光法检测HER2/neu的蛋白表达,FCM分析细胞周期变化,MTT法观察细胞生长.结果:肺腺癌细胞系SPCA1存在HER2/neu过表达;成功构建了HER2/neu特异性RNA干涉载体pSUPERsiHER2;瞬时转染SPCA1细胞,HER2/neu的mRNA及蛋白表达均降低;G1期细胞较亲代增加9.9%;肿瘤细胞增殖速度减慢(P<0.05).结论:成功构建了HER2/neuRNA干涉载体,转染后可有效降低肺腺癌细胞系SPCA1HER2/neu的mRNA转录及蛋白水平表达,阻滞转染细胞于G1期,造成转染细胞生长速度减慢,这有望为肺癌基因治疗提供一种选择手段. AIM: To construct RNA interference (RNAi) vector to down-regulate HER2/neu gene and study the RNAi effect on the cell cycle and tumor growth of non-small cell lung cancer. METHODS: Oligonucleotides of 64 base pairs for hairpin RNA targeting HER2/neu were designed, chemically synthesized and annealed, and cloned into pSUPER vector. After identified by restriction digestion, the right vectors were transiently transfected into SPC-A-1 cells, a human lung adenocarcinoma cell line. The HER2 mRNA was detected by RT-PCR, and the protein detected by Western blot and indirect immunolluorescence staining. FCM analysis and MTT method were applied to measure cell cycle and cell growth respectively. RESULTS: SPC-A-1 cells had an overexpression of HER2. The vector of RNAi which can interfere HER2/neu gene was successfully constructed, and compared with parent cells, the vector can increase the number of cells in G0/GI phase by 9.9%, and inhibit the tumor cell growth ( P 〈 0.05 ). CONCLUSION: We successfully constructed an expressing hairpin RNA against HER2/neu vector. The vector can effectively silence HER2/neu gene, increase the number of cells in G0/GI phase, and then slow down the growth of tumor cells. This may be a useful therapeutic strategy for NSCLC over-expressing HER2/ neu.
出处 《第四军医大学学报》 北大核心 2006年第9期828-831,共4页 Journal of the Fourth Military Medical University
基金 国家重大基础研究计划项目"973"(2004CB518805) 教育部"长江学者和创新团队发展计划"项目(IRT0459)
关键词 SIRNA RNA干涉 HER2/NEU 非小细胞肺癌 癌细胞生长 抑制作用 siRNA RNAi carcinoma, non-small-cell lung HER2/neu
  • 相关文献

参考文献14

  • 1Tsai CM,Chang KT.Interrelationship between cellular nucleotide excision repair,cisplatin cytotoxicity and EGFR in NSCLC[J].J Cancer Res,2000,91(2):213-222.
  • 2Atalay G,Cardoso F,Awada A,et al.Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer[J].Ann Oncol,2003,14(9):1346-1363.
  • 3Turken O,Kunter E,Cermik H,et al.Prevalence and prognostic value of c-erbB2 expression in non-small cell lung cancer (NSCLC)[J].Neoplasma,2003,50(4):257-261.
  • 4Perez-Soler R.HER1/EGFR targeting:Refining the strategy[J].Oncologist,2004,9(1):58-67.
  • 5Ma J,Kahwaji CI,Ni Z,et al.Effects of simulated microgravity on arterial nitric oxide synthese and nitrate and nitrite content[J].J Appl Physiol,2003,94(1):83-92.
  • 6Zhao J,Zhang LH,Jia LT,et al.Secreted antibody/granzyme B fusion protein stimulates selective killing of HER2-overexpressing tumor cells[J].J Biol Chem,2004,279(20):21343-21348.
  • 7Krug LM,Miller VA,Patel J,et al.Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced non small cell lung carcinoma[J].Cancer,2005,104(10):2149-2155.
  • 8Clamon G,Herndon J,Kern J,et al.Lack of trastuzumab activity in non small cell lung carcinoma with overexpression of erb-B2:39810:A phase II trial of Cancer and Leukemia Group B[J].Cancer,2005,103(8):1670-1675.
  • 9Milhavet O,Gary DS,Mattson MP.RNA interference in biology and medicine[J].Pharmacol Rev,2003,55(4):629-648.
  • 10Scherr M,Battmer K,Schuhheis B,et al.Stable RNA interference (RNAi)and an option for anti-bcr-abl therapy[J].Gene Ther,2005,12(1):12-21.

同被引文献34

  • 1杨华强,万楚成.Mcl-1与血液恶性肿瘤[J].中华肿瘤防治杂志,2007,14(6):467-469. 被引量:1
  • 2石川,曹以诚,杜正平,卓敏.RNAi抑制丙肝病毒复制的研究进展[J].现代食品科技,2007,23(6):59-62. 被引量:3
  • 3Han J,Goldstein L A,Gastman B R,et al.Disruption of Mcl-1/Bim complex in granzyme B-mediated mitochondrial apoptosis[J].J Biol.Chem.,2005,280(16):16383-16392.
  • 4Willis S N,Chen L,Dewson G,et al.Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL,but not Bcl-2,until displaced by BH3-only proteins[J].Genes Dev.,2005,19(11):1294-1305.
  • 5Chen L,Willis S N,Wei A,et al.Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function[J].Mol.Cell,2005,17(3):393-403.
  • 6Song L,Coppola D,Livingston S,et al.Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli inhuman nonsmall lung cancer cells[J].Cancer Biol.Ther.,2005,4(3):e52-e74.
  • 7Cho-Vega J H,Rassida Kis G Z,Admirand J H,et al.Mcl-1 expression in B cell nonHodgkin's lymphomas[J].Hum Pat hol,2004,35(9):1095-1110.
  • 8Moulding D A,Giles R V,Spiller D G,et al.Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937cells[J].Blood,2000,96(5):1756-1763.
  • 9Derenne S,Monia B,Dean N M,et al.Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bclx(L)is an essential survival protein of human myeloma cells[J] ,Blood,2002,100(1):194-199.
  • 10Backus H H,vanRiel J M,vanGroeningen C J,et al.Rb,mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer[J].Ann.Onco l.,2001,12(6):779-785.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部